SG11201403406PA - Biocompatible method of functionalising substrates with inert surfaces - Google Patents

Biocompatible method of functionalising substrates with inert surfaces

Info

Publication number
SG11201403406PA
SG11201403406PA SG11201403406PA SG11201403406PA SG11201403406PA SG 11201403406P A SG11201403406P A SG 11201403406PA SG 11201403406P A SG11201403406P A SG 11201403406PA SG 11201403406P A SG11201403406P A SG 11201403406PA SG 11201403406P A SG11201403406P A SG 11201403406PA
Authority
SG
Singapore
Prior art keywords
international
functionalising
auckland
street
stephen
Prior art date
Application number
SG11201403406PA
Inventor
Stephen Micheal Henry
Stephen Robert Parker
Original Assignee
Stephen Micheal Henry
Stephen Robert Parker
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stephen Micheal Henry, Stephen Robert Parker filed Critical Stephen Micheal Henry
Publication of SG11201403406PA publication Critical patent/SG11201403406PA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D65/00—Accessories or auxiliary operations, in general, for separation processes or apparatus using semi-permeable membranes
    • B01D65/08—Prevention of membrane fouling or of concentration polarisation
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
    • C08G64/42—Chemical after-treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G01N2001/4088—Concentrating samples by other techniques involving separation of suspended solids filtration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)

Abstract

(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 9 January 2014 (09.01.2014) WIPOIPCT (10) International Publication Number WO 2014/007649 A1 (51) International Patent Classification: G01N33/48 (2006.01) G01N33/543 (2006.01) G01N33/53 (2006.01) (21) International Application Number: (22) International Filing Date: (25) Filing Language: (26) Publication Language: (30) Priority Data: PCT/NZ2012/000242 19 December 2012 (19.12.2012) English 597207 19 December 2011 (19.12.2011) 601745 9 August 2012 (09.08.2012) (72) Inventors; and (71) Applicants : HENRY, Stephen Micheal [NZ/NZ]; 3 Lonsdale Street, Ellerslie, Auckland (NZ). PARKER, Stephen Robert [GB/NZ]; Level 31, Vero Centre, 48 Shortland Street, Auckland, 1010 (NZ). AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. NZ NZ English (84) Designated States (unless otherwise indicated, for every kind of regional protection available)'. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG). (74) Agent: PARKER, Stephen Robert; Level 31, Vero Centre, 48 Shortland Street, Auckland, 1010 (NZ). (81) Designated States (unless otherwise indicated, for every kind of national protection available)'. AE, AG, AL, AM, Published: — with international search report (Art. 21(3)) 0\ •t l> o o o CJ o & (54) Title: BIOCOMPATIBLE METHOD OF FUNCTIONALISING SUBSTRATES WITH INERT SURFACES (57) Abstract: Biocompatible methods of functionalising inert surfaces for use in biological applications are described. The methods employ the use of synthetic constructs of the generic structure F-S-L (where F is a functional moiety, S is a spacer selected to provide a construct that is dispersible in water, and L is a diacyl- or dialkyl- glycerophospholipid). An object of the invention is to localise or immobilise functional moieties to the inert surface of substrate wherein a the surface comprised is of glass, silver, poly - amide, polycarbonate, polypropylene, polyethersulfone, polytetrafluoroethylene or polyvinylidene fluoride, and the substrate is com­ prised of fibre, membrane, microsphere a or nanosphere.
SG11201403406PA 2011-12-19 2012-12-19 Biocompatible method of functionalising substrates with inert surfaces SG11201403406PA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ59720711 2011-12-19
NZ60174512 2012-08-09
PCT/NZ2012/000242 WO2014007649A1 (en) 2011-12-19 2012-12-19 Biocompatible method of functionalising substrates with inert surfaces

Publications (1)

Publication Number Publication Date
SG11201403406PA true SG11201403406PA (en) 2014-12-30

Family

ID=48874618

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201403406PA SG11201403406PA (en) 2011-12-19 2012-12-19 Biocompatible method of functionalising substrates with inert surfaces

Country Status (4)

Country Link
US (2) US9528139B2 (en)
EP (1) EP2795316B1 (en)
SG (1) SG11201403406PA (en)
WO (1) WO2014007649A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11073451B2 (en) 2011-12-19 2021-07-27 Kode Biotech Limited Biocompatible method of functionalising substrates with inert surfaces
JP2018500144A (en) * 2014-11-03 2018-01-11 ボヴィン、ニコライ ウラジミロヴィチＢＯＶＩＮ，Ｎｉｃｏｌａｉ Ｖｌａｄｉｍｉｒｏｖｉｃｈ Antimicrobial surface treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0800278D0 (en) 2008-01-08 2008-02-13 Glysure Ltd Surface functionalisation
CA2766110C (en) * 2009-06-29 2018-07-17 Nicolai Vladimirovich Bovin Printing of fsl constructs
US20110042299A1 (en) 2009-08-20 2011-02-24 General Electric Company Composite membrane assemblies and methods of making and using the same
GB2500854B (en) * 2011-01-06 2019-04-17 Vladimirovich Bovin Nicolai Biosurface engineering

Also Published As

Publication number Publication date
EP2795316A1 (en) 2014-10-29
WO2014007649A1 (en) 2014-01-09
US20140370538A1 (en) 2014-12-18
AU2012364662A1 (en) 2013-08-01
EP2795316B1 (en) 2017-09-06
US9528139B2 (en) 2016-12-27
AU2012364662A8 (en) 2015-01-22
AU2012364662B2 (en) 2014-09-25
US20170219467A1 (en) 2017-08-03
US10215672B2 (en) 2019-02-26
EP2795316A4 (en) 2015-07-01

Similar Documents

Publication Publication Date Title
SG11201810600WA (en) Fxr (nr1h4) modulating compounds
SG11201808622SA (en) Chimeric receptors to flt3 and methods of use thereof
SG11201804398XA (en) Method for producing rna molecule compositions
SG11201903480TA (en) Cell culture device system and methods of use thereof
SG11201407580YA (en) Composition comprising two antibodies engineered to have reduced and increased effector function
SG11201407233RA (en) Ethylene oligomerization process
SG11201403106SA (en) Anti-phf-tau antibodies and their uses
SG11201408261UA (en) Syringe
SG11201406787TA (en) Rnai-based therapies for cardiomyopathies, muscular dystrophies and laminopathies
SG11201408251SA (en) A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
SG11201408303WA (en) Adhesive compositions of propylene-based and ethylene-based polymers
SG11201406903SA (en) Cell culture compositions and methods for polypeptide production
SG11201805898RA (en) Liquid composition comprising a multistage polymer, its method of preparation and its use
SG11201408750VA (en) NOVEL FUSED PYRIDINE DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS
SG11201408198QA (en) Jumper tube locking assembly and method
SG11201810177VA (en) Pet-imaging immunomodulators
SG11201407800SA (en) Selective binding of biological targets to solid phase ureides
SG11201908075UA (en) A microneedle device
SG11201407812SA (en) Methods for reducing levels of protein-contaminant complexes and aggregates in protein preparations by treatment with electropositive organic additives
SG11201408224SA (en) Novel ruthenium complexes, their use in the metathesis reactions, and a process for carrying out the metathesis reaction
SG11201408451WA (en) Use of vacuum chucks to hold a wafer or wafer sub-stack
SG11201900633XA (en) Piperidine cxcr7 receptor modulators
SG11201407988UA (en) Process for improved opioid synthesis
SG11201408396QA (en) Improved resid hydrotreating catalyst containing titania
SG11201408434QA (en) Targeted rna-seq methods and materials for the diagnosis of prostate cancer